Commentary on Anand et al
- PMID: 22167110
- DOI: 10.1177/1740774511427169
Commentary on Anand et al
Comment on
-
What information should a sponsor of a randomized trial receive during its conduct?Clin Trials. 2011 Dec;8(6):716-9. doi: 10.1177/1740774511424421. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024103
Similar articles
-
Commentary on Anand et al.Clin Trials. 2011 Dec;8(6):722-3; discussion 726. doi: 10.1177/1740774511426581. Clin Trials. 2011. PMID: 22167109 No abstract available.
-
Commentary on Anand et al.Clin Trials. 2011 Dec;8(6):720-1; discussion 726. doi: 10.1177/1740774511425692. Clin Trials. 2011. PMID: 22167108 No abstract available.
-
What information should a sponsor of a randomized trial receive during its conduct?Clin Trials. 2011 Dec;8(6):716-9. doi: 10.1177/1740774511424421. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024103
-
Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.Aust Fam Physician. 2004 Nov;33(11):950-1, 956. Aust Fam Physician. 2004. PMID: 15584339 Review. No abstract available.
-
Design of randomized controlled trials.Circulation. 2007 Mar 6;115(9):1164-9. doi: 10.1161/CIRCULATIONAHA.105.594945. Circulation. 2007. PMID: 17339574 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources